BLUEX | QLEIX | BLUEX / QLEIX | |
Total Expense Ratio | 1.16 | 5.33 | 22% |
Annual Report Gross Expense Ratio | 1.24 | 5.33 | 23% |
Fund Existence | 35 years | 12 years | - |
Gain YTD | 5.374 | 19.226 | 28% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 2000 | 5000000 | 0% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 101M | 5.49B | 2% |
Annual Yield % from dividends | 0.28 | 6.11 | 5% |
Returns for 1 year | 6.39 | 30.05 | 21% |
Returns for 3 years | 4.52 | 106.01 | 4% |
Returns for 5 years | -24.69 | 185.56 | -13% |
Returns for 10 years | 10.39 | 150.39 | 7% |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
ETHSX | 12.81 | 0.14 | +1.10% |
Eaton Vance Worldwide Health Sci A | |||
LMPMX | 39.14 | 0.01 | +0.03% |
ClearBridge Small Cap Growth 1 | |||
ACEIX | 11.01 | -0.03 | -0.27% |
Invesco Equity and Income A | |||
AMCGX | 10.95 | -0.03 | -0.27% |
Alger Mid Cap Growth B | |||
NBRVX | 26.42 | -0.11 | -0.41% |
Neuberger Berman M/C Intrinsic Val Inv |